Xcout Intel
PAINCHEK LTD
PainChek Limited specializes in the creation and commercialization of mobile medical applications designed for individual pain assessment. Their core product, PainChek, employs smartphone and tablet cameras to record video, which is then analyzed in real-time by facial recognition software to detect the presence of pain. This technology is particularly beneficial for patients suffering from dementia. The company, which operates from its headquarters in Sydney, Australia, rebranded as PainChek Limited in January 2018, having previously been known as ePAT Technologies Ltd.
Subscribe to see PAINCHEK LTD’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PAINCHEK LTD at a glance
PAINCHEK LTD is a health care equipment & services company headquartered in Sydney, Australia. It is publicly listed (PCK) with a market capitalisation of $14.9M. Xcout tracks 9 named people at PAINCHEK LTD, including David Hammer (Portfolio Manager).
PAINCHEK LTD leadership
- David HammerPortfolio Manager
- David Nichols Iii FisherDirector
- Derrick Alan ClarkDirector
- Elizabeth Davis CantrillDirector
- Grace VandecruzeDirector
- Joseph Baker Jr KittredgeDirector
3 more named people on record for PAINCHEK LTD, with roles, board committees and tenure — see the full roster →
PAINCHEK LTD competitors
A few of PAINCHEK LTD's closest competitors — see the full list of competitors and alternatives →
Neurotech International Limited (NTI.AX), along with its subsidiaries, is an Australian firm dedicated to the research, development, and manufacture of innovative medical devices and solutions. The company's primary focus lies in advancing and commercializing its Mente platform, a technological system designed to monitor and facilitate home-based therapies. This includes its Mente Autism product, specifically aimed at the diagnosis and treatment of autism spectrum disorder. Additionally, Neurotech actively undertakes various medical research projects and engineers new technological instruments. The company was established in 2016 and maintains its headquarters in Nedlands, Australia.
Headquartered in Melbourne, Australia, Vitasora Health Limited specializes in the research, development, and market introduction of medical devices across Australia and the United States. The company's portfolio also includes the creation of mobile health applications. Notably, the firm, previously known as Respiri Limited, officially rebranded as Vitasora Health Limited in April 2025.
Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.
Based in Melbourne, Australia, Respiri Limited operates as an e-health software-as-a-service (SaaS) provider. The company is dedicated to the research, development, and commercialization of medical devices across Australia, and also creates, manufactures, and distributes mobile health applications. Its key offerings include wheezo, an innovative electronic tool specifically designed for identifying wheezing in children, along with the Respiri mobile application and the Respiri health portal. The organization officially became Respiri Limited in December 2015, having previously conducted business as iSonea Limited.
MedX Health Corp. develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It offers SIAscopy on DermSecure telemedicine platform, which is used to scan skin for suspicious moles and lesions, and phototherapeutic medical devices. Its brands include the DermSecure, MoleMate, SIMSYS, and SIAMETRICS. The company was founded on April 15, 1999 and is headquartered in Mississauga, Canada.
Lifespark Technologies is a healthcare technology company headquartered in Mumbai, India, that builds innovative digital solutions and assistive devices for neurological conditions such as Parkinson's Disease and stroke.
Get PAINCHEK LTD's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on PAINCHEK LTD in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access